Table 4. Meta-analysis summary of standardization of laboratory indicators of surviving cases and death cases.
| Anomaly indicator | SMD (95% CI) | P value | I2 (%) | Included literature | Death cases | Surviving cases |
|---|---|---|---|---|---|---|
| Inflammatory factors | ||||||
| IL-6 | 2.62 (2.15, 3.09) | <0.001 | 78 | 2 | 33 | 152 |
| PCT | 0.2 (0.16, 0.23) | <0.001 | 39 | 2 | 29 | 127 |
| Routine blood indicators | ||||||
| neutrophils | 2.77 (2.38, 3.16) | <0.001 | 55 | 3 | 54 | 206 |
| Lymphocyte count | −2.1 (−2.46, −1.75) | <0.001 | 77 | 3 | 54 | 206 |
| Biochemical indicator | ||||||
| Creatinine | 2.29 (1.87, 2.7) | <0.001 | 96 | 2 | 42 | 171 |
SMD, standardized mean difference; 95% CI, 95% confidence interval; I2 (%), heterogeneity; IL-6, interleukin 6; PCT, procalcitonin.